0001104659-23-119592.txt : 20231117 0001104659-23-119592.hdr.sgml : 20231117 20231117170035 ACCESSION NUMBER: 0001104659-23-119592 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231115 FILED AS OF DATE: 20231117 DATE AS OF CHANGE: 20231117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hudson Frederick M. CENTRAL INDEX KEY: 0001438462 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 231419734 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4 1 tm2331055-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-11-15 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001438462 Hudson Frederick M. C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE ROCKVILLE MD 20850 1 0 0 0 0 Common Stock 2023-11-15 4 M 0 7457 9.24 A 42324 D Common Stock 2023-11-15 4 S 0 3882 28.50 D 38442 D Common Stock 2023-11-15 4 S 0 5211 28.50 D 33231 D Director Stock Option (Right to Buy) 9.24 2023-11-15 4 M 0 7457 0 D 2015-01-21 2024-01-21 Common Stock 7457 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.49 to $28.53, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. /s/ Timothy C. Dec, as attorney-in-fact 2023-11-17